Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003006 · ClinicalTrials.gov registry record
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 501
- Enrollment target
NCT00003006 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 501 participants.
The verdict
NCT00003006 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 501 participants
- Enrollment target
Study Summary
RATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer. PURPOSE: Clinical trial to detect the presence of metastatic cancer in patients with stage I non-small cell lung cancer that has not been previously treated.
Interventions
- OTHER immunohistochemistry staining method
- GENETIC reverse transcriptase-polymerase chain reaction
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 501 participants |
| Start Date | 1997-05 |
| Est. Completion | 2010-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003006
The ClinicalTrials.gov registry entry for NCT00003006 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 501 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which immunohistochemistry staining method is the first listed.
NCT00003006 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00003006 about?
NCT00003006 is a clinical study titled "Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer". RATIONALE: Detecting very early metastases in bone marrow and/or lymph nodes may help doctors plan better treatment for non-small cell lung cancer. PURPOSE: Clinical trial to detect the presence of metastatic cancer in patients with stage I non-small cell lung cancer that has not been previously tr...
What is the current status of trial NCT00003006?
This trial is currently completed. The enrollment target is 501 participants. The study started on 1997-05. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00003006?
The interventions under investigation include: immunohistochemistry staining method (OTHER), reverse transcriptase-polymerase chain reaction (GENETIC).
Who is sponsoring clinical trial NCT00003006?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.